Global Human Milk Oligosaccharides HMO Market Research Report 2023(Status and Outlook)
Report Overview
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Global Human Milk Oligosaccharides (HMO) key players include Abbott, Inbiose, Elicityl SA, Jennewein Biotechnologie, ZuChem, etc. North America is the largest consumption market, with a share about 65%, followed by Europe, with a share about 30 percent. In terms of product, 2'-FL & 3-FL is the largest segment, with a share about 70%. And in terms of application, the largest application is Infant Formula, followed by Functional Food & Beverages, and Food/Medical Supplements.
The Global Human Milk Oligosaccharides HMO Market Size was estimated at USD 385.00 million in 2022 and is projected to reach USD 2494.96 million by 2029, exhibiting a CAGR of 30.60% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Human Milk Oligosaccharides HMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Milk Oligosaccharides HMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Milk Oligosaccharides HMO market in any manner.
Global Human Milk Oligosaccharides HMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Inbiose
Elicityl SA
Jennewein Biotechnologie
ZuChem
Dextra Laboratories
Glycom
Market Segmentation (by Type)
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
Market Segmentation (by Application)
Shopping Malls
Baby Store
Online Channel
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Milk Oligosaccharides HMO Market
Overview of the regional outlook of the Human Milk Oligosaccharides HMO Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Human Milk Oligosaccharides HMO
- 1.2 Key Market Segments
- 1.2.1 Human Milk Oligosaccharides HMO Segment by Type
- 1.2.2 Human Milk Oligosaccharides HMO Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Human Milk Oligosaccharides HMO Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Human Milk Oligosaccharides HMO Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Human Milk Oligosaccharides HMO Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Human Milk Oligosaccharides HMO Market Competitive Landscape
- 3.1 Global Human Milk Oligosaccharides HMO Sales by Manufacturers (2018-2023)
- 3.2 Global Human Milk Oligosaccharides HMO Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Human Milk Oligosaccharides HMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Human Milk Oligosaccharides HMO Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Human Milk Oligosaccharides HMO Sales Sites, Area Served, Product Type
- 3.6 Human Milk Oligosaccharides HMO Market Competitive Situation and Trends
- 3.6.1 Human Milk Oligosaccharides HMO Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Human Milk Oligosaccharides HMO Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Human Milk Oligosaccharides HMO Industry Chain Analysis
- 4.1 Human Milk Oligosaccharides HMO Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Human Milk Oligosaccharides HMO Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Human Milk Oligosaccharides HMO Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Human Milk Oligosaccharides HMO Sales Market Share by Type (2018-2023)
- 6.3 Global Human Milk Oligosaccharides HMO Market Size Market Share by Type (2018-2023)
- 6.4 Global Human Milk Oligosaccharides HMO Price by Type (2018-2023)
- 7 Human Milk Oligosaccharides HMO Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Human Milk Oligosaccharides HMO Market Sales by Application (2018-2023)
- 7.3 Global Human Milk Oligosaccharides HMO Market Size (M USD) by Application (2018-2023)
- 7.4 Global Human Milk Oligosaccharides HMO Sales Growth Rate by Application (2018-2023)
- 8 Human Milk Oligosaccharides HMO Market Segmentation by Region
- 8.1 Global Human Milk Oligosaccharides HMO Sales by Region
- 8.1.1 Global Human Milk Oligosaccharides HMO Sales by Region
- 8.1.2 Global Human Milk Oligosaccharides HMO Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Human Milk Oligosaccharides HMO Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Human Milk Oligosaccharides HMO Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Human Milk Oligosaccharides HMO Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Human Milk Oligosaccharides HMO Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Human Milk Oligosaccharides HMO Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Abbott
- 9.1.1 Abbott Human Milk Oligosaccharides HMO Basic Information
- 9.1.2 Abbott Human Milk Oligosaccharides HMO Product Overview
- 9.1.3 Abbott Human Milk Oligosaccharides HMO Product Market Performance
- 9.1.4 Abbott Business Overview
- 9.1.5 Abbott Human Milk Oligosaccharides HMO SWOT Analysis
- 9.1.6 Abbott Recent Developments
- 9.2 Inbiose
- 9.2.1 Inbiose Human Milk Oligosaccharides HMO Basic Information
- 9.2.2 Inbiose Human Milk Oligosaccharides HMO Product Overview
- 9.2.3 Inbiose Human Milk Oligosaccharides HMO Product Market Performance
- 9.2.4 Inbiose Business Overview
- 9.2.5 Inbiose Human Milk Oligosaccharides HMO SWOT Analysis
- 9.2.6 Inbiose Recent Developments
- 9.3 Elicityl SA
- 9.3.1 Elicityl SA Human Milk Oligosaccharides HMO Basic Information
- 9.3.2 Elicityl SA Human Milk Oligosaccharides HMO Product Overview
- 9.3.3 Elicityl SA Human Milk Oligosaccharides HMO Product Market Performance
- 9.3.4 Elicityl SA Business Overview
- 9.3.5 Elicityl SA Human Milk Oligosaccharides HMO SWOT Analysis
- 9.3.6 Elicityl SA Recent Developments
- 9.4 Jennewein Biotechnologie
- 9.4.1 Jennewein Biotechnologie Human Milk Oligosaccharides HMO Basic Information
- 9.4.2 Jennewein Biotechnologie Human Milk Oligosaccharides HMO Product Overview
- 9.4.3 Jennewein Biotechnologie Human Milk Oligosaccharides HMO Product Market Performance
- 9.4.4 Jennewein Biotechnologie Business Overview
- 9.4.5 Jennewein Biotechnologie Human Milk Oligosaccharides HMO SWOT Analysis
- 9.4.6 Jennewein Biotechnologie Recent Developments
- 9.5 ZuChem
- 9.5.1 ZuChem Human Milk Oligosaccharides HMO Basic Information
- 9.5.2 ZuChem Human Milk Oligosaccharides HMO Product Overview
- 9.5.3 ZuChem Human Milk Oligosaccharides HMO Product Market Performance
- 9.5.4 ZuChem Business Overview
- 9.5.5 ZuChem Human Milk Oligosaccharides HMO SWOT Analysis
- 9.5.6 ZuChem Recent Developments
- 9.6 Dextra Laboratories
- 9.6.1 Dextra Laboratories Human Milk Oligosaccharides HMO Basic Information
- 9.6.2 Dextra Laboratories Human Milk Oligosaccharides HMO Product Overview
- 9.6.3 Dextra Laboratories Human Milk Oligosaccharides HMO Product Market Performance
- 9.6.4 Dextra Laboratories Business Overview
- 9.6.5 Dextra Laboratories Recent Developments
- 9.7 Glycom
- 9.7.1 Glycom Human Milk Oligosaccharides HMO Basic Information
- 9.7.2 Glycom Human Milk Oligosaccharides HMO Product Overview
- 9.7.3 Glycom Human Milk Oligosaccharides HMO Product Market Performance
- 9.7.4 Glycom Business Overview
- 9.7.5 Glycom Recent Developments
- 10 Human Milk Oligosaccharides HMO Market Forecast by Region
- 10.1 Global Human Milk Oligosaccharides HMO Market Size Forecast
- 10.2 Global Human Milk Oligosaccharides HMO Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Human Milk Oligosaccharides HMO Market Size Forecast by Country
- 10.2.3 Asia Pacific Human Milk Oligosaccharides HMO Market Size Forecast by Region
- 10.2.4 South America Human Milk Oligosaccharides HMO Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Human Milk Oligosaccharides HMO by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Human Milk Oligosaccharides HMO Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Human Milk Oligosaccharides HMO by Type (2024-2029)
- 11.1.2 Global Human Milk Oligosaccharides HMO Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Human Milk Oligosaccharides HMO by Type (2024-2029)
- 11.2 Global Human Milk Oligosaccharides HMO Market Forecast by Application (2024-2029)
- 11.2.1 Global Human Milk Oligosaccharides HMO Sales (K MT) Forecast by Application
- 11.2.2 Global Human Milk Oligosaccharides HMO Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook